miR‑760 mediates hypoxia-induced proliferation and apoptosis of human pulmonary artery smooth muscle cells via targeting TLR4

Yang,Yu‑Zhong; Zhang,Yun‑Feng; Yang,Lei; Xu,Jing; Mo,Xu‑Ming; Peng,Wei

doi:10.3892/ijmm.2018.3862

miR‑760 mediates hypoxia-induced proliferation and apoptosis of human pulmonary artery smooth muscle cells via targeting TLR4

Authors:
- Yu‑Zhong Yang
- Yun‑Feng Zhang
- Lei Yang
- Jing Xu
- Xu‑Ming Mo
- Wei Peng
View Affiliations

Affiliations: Department of Cardiothoracic Surgery, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, P.R. China, Department of Pharmacy, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, P.R. China, Department of Digestion, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, P.R. China
Published online on: September 7, 2018 https://doi.org/10.3892/ijmm.2018.3862
Pages: 2437-2446
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miRNAs) have a key role in the pathogenesis of pulmonary arterial hypertension (PAH), a disease characterized by enhanced proliferation and reduced apoptosis of pulmonary artery smooth muscle cells. In the present study, miR‑760 was demonstrated to be downregulated in PAH lung tissues compared with normal lung tissues, an effect that may be associated with the development of PAH. Hypoxia is an important stimulus for human pulmonary artery smooth muscle cell (hPASMC) proliferation and the occurrence of PAH. Therefore, the effect of miR‑760 in hypoxia‑treated and normal hPASMCs was investigated. Expression of exogenous miR‑760 decreased cell proliferation in hypoxia‑induced hPASMCs, and promoted cell apoptosis with an increase in the BCL2 associated X/BCL2 ratio and the expression levels of Caspase‑3 and Caspase‑9. In addition, overexpression of miR‑760 suppressed the migration of hPASMCs under hypoxic conditions. Furthermore, miR‑760 was demonstrated to mediate its anti‑proliferation effect via the regulation of toll‑like receptor 4 (TLR4), a direct target of miR‑760. The results revealed that knockdown of TLR4 restrained the hypoxia‑induced hPASMC proliferation and induced cell apoptosis. The present study uncovered a novel regulatory pathway involving miR‑760 and suggested that miR‑760 may be explored as a potential therapy for PAH in the future.

View Figures

View References

1	Sa hoo S, Meijles DN, Ghouleh I A, Tandon M, Cifuentes-Pagano E, Sembrat J, Rojas M, Goncharova E and Pagano PJ: MEF2C-MYOCD and Leiomodin1 suppression by miRNA-214 promotes smooth muscle cell phenotype switching in pulmonary arterial hypertension. PLoS One. 11:–e0153780. 2016.
2	Farber HW and Loscalzo J: Mechanisms of disease: Pulmonary arterial hypertension. N Engl J Med. 351:1655–1665. 2004. View Article : Google Scholar : PubMed/NCBI
3	Tuder RM, Marecki JC, Richter A, Fijalkowska I and Flores S: Pathology of pulmonary hypertension. Clin Chest Med. 28:23–42. 2007. View Article : Google Scholar : PubMed/NCBI
4	Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, et al: Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol. 54:S20–S31. 2009. View Article : Google Scholar : PubMed/NCBI
5	Hadri L, Kratlian RG, Benard L, Maron BA, Dorfmüller P, Ladage D, Guignabert C, Ishikawa K, Aguero J, Ibanez B, et al: Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension. Circulation. 128:512–523. 2013. View Article : Google Scholar
6	Rubin LJ, Simonneau G, Badesch D, Galiè N, Humbert M, Keogh A, Massaro J, Matucci Cerinic M, Sitbon O and Kymes S: The study of risk in pulmonary arterial hypertension. Eur Respir Rev. 21:234–238. 2012. View Article : Google Scholar : PubMed/NCBI
7	Farh KK, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP, Burge CB and Bartel DP: The widespread impact of mammalian micrornas on mrna repression and evolution. Science. 310:1817–1821. 2005. View Article : Google Scholar : PubMed/NCBI
8	Arunachalam G, Upadhyay R, Ding H and Triggle CR: MicroRNA signature and sardiovascular dysfunction. J Cardiovasc Pharmacol. 65:419–29. 2015. View Article : Google Scholar
9	Bienertova-Vasku J, Novak J and Vasku A: MicroRNAs in pulmonary arterial hypertension: Pathogenesis, diagnosis and treatment. J Am Soc Hypertens. 9:221–34. 2015. View Article : Google Scholar : PubMed/NCBI
10	Sharma S, Umar S, Potus F, Iorga A, Wong G, Meriwether D, Breuils-Bonnet S, Mai D, Navab K, Ross D, et al: ApoA-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p. Circulation. 130:776–785. 2014. View Article : Google Scholar : PubMed/NCBI
11	Courboulin A, Paulin R, Giguere NJ, Saksouk N, Perreault T, Meloche J, Paquet ER, Biardel S, Provencher S, Côté J, et al: Role for miR-204 in human pulmonary arterial hypertension. J Exp Med. 208:535–548. 2011. View Article : Google Scholar : PubMed/NCBI
12	Qian Z, Li Y, Chen J, Li X and Gou D: miR-4632 mediates PDGF-BB-induced proliferation and antiapoptosis of human pulmonary artery smooth muscle cells via targeting cJUN. Am J Physiol Cell Physiol. 313:C380–C391. 2017. View Article : Google Scholar : PubMed/NCBI
13	Lu Z, Li S, Zhao S and Fa X: Upregulated miR-17 regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation and apoptosis by targeting mitofusin 2. Med Sci Monit. 22:3301–3308. 2016. View Article : Google Scholar : PubMed/NCBI
14	Elshafei A, Shaker O, Abd-El-Motaal O and Salman T: The expression profiling of serum miR-92a, miR-375, and miR-760 in colorectal cancer: An Egyptian study. Tumor Biol. 39:10104283177057652017. View Article : Google Scholar
15	Hu SH, Wang CH, Huang ZJ, Liu F, Xu CW, Li XL and Chen GQ: miR-760 mediates chemoresistance through inhibition of epithelial mesenchymal transition in breast cancer cells. Eur Rev Med Pharmacol Sci. 20:5002–5008. 2016.PubMed/NCBI
16	Hao H, Gabbiani G and Bochaton-Piallat ML: Arterial smooth muscle cell heterogeneity: Implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol. 23:1510–1520. 2003. View Article : Google Scholar : PubMed/NCBI
17	Sysol JR, Chen J, Singla S, Zhao S, Comhair S, Natarajan V and Machado RF: MicroRNA-1 is decreased by hypoxia and contributes to the development of pulmonary vascular remodeling via regulation of sphingosine kinase 1. Am J Physiol Lung Cell Mol Physiol. 314:L461–L472. 2018. View Article : Google Scholar
18	Aytekin M, Comhair SA, de la Motte C, Bandyopadhyay SK, Farver CF, Hascall VC, Erzurum SC and Dweik RA: High levels of hyaluronan in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 295:L789–L799. 2008. View Article : Google Scholar : PubMed/NCBI
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T) method. Method. 25:402–408. 2001. View Article : Google Scholar
20	Mizuno S, Bogaard HJ, Kraskauskas D, Alhussaini A, Gomez-Arroyo J, Voelkel NF and Ishizaki T: p53 gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice. Am J Physiol Lung Cell Mol Physiol. 300:L753–L761. 2011. View Article : Google Scholar : PubMed/NCBI
21	Ma J, Liang S, Wang Z, Zhang L, Jiang J, Zheng J, Yu L, Zheng X, Wang R and Zhu D: ROCK pathway participates in the processes that 15-hydroxyeicosatetraenoic acid (15-HETE) mediated the pulmonary vascular remodeling induced by hypoxia in rat. J Cell Physiol. 222:82–94. 2010. View Article : Google Scholar
22	Jalali S, Ramanathan GK, Parthasarathy PT, Aljubran S, Galam L, Yunus A, Garcia S, Cox RR Jr, Lockey RF and Kolliputi N: Mir-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation. PLoS One. 7:e468082012. View Article : Google Scholar : PubMed/NCBI
23	Agarwal V, Bell GW, Nam JW and Bartel DP: Predicting effective mircoRNA target sites in mammalian mRNA. Elife. 4:2015. View Article : Google Scholar
24	de Jesus Perez V, Yuan K, Alastalo TP, Spiekerkoetter E and Rabinovitch M: Targeting the Wnt signaling pathways in pulmonary arterial hypertension. Drug Discov Today. 19:1270–1276. 2014. View Article : Google Scholar : PubMed/NCBI
25	Anwar A, Li M, Frid MG, Kumar B, Gerasimovskaya EV, Riddle SR, McKeon BA, Thukaram R, Meyrick BO, Fini MA and Stenmark KR: Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 303:L1–L11. 2012. View Article : Google Scholar : PubMed/NCBI
26	McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, et al: ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 53:1573–1619. 2009. View Article : Google Scholar : PubMed/NCBI
27	Liu A, Philip J, Vinnakota KC, Van den Bergh F, Tabima DM, Hacker T, Beard DA and Chesler NC: Estrogen maintains mitochondrial content and function in the right ventricle of rats with pulmonary hypertension. Physiol Rep. 5:e131572017. View Article : Google Scholar : PubMed/NCBI
28	Jin H, Wang Y, Zhou L, Liu L, Zhang P, Deng W and Yuan Y: Melatonin attenuates hypoxic pulmonary hypertension by inhibiting the inflammation and the proliferation of pulmonary arterial smooth muscle cells. J Pineal Res. 57:442–450. 2014. View Article : Google Scholar : PubMed/NCBI
29	Welsh DJ and Peacock AJ: Cellular responses to hypoxia in the pulmonary circulation. High Alt Med Biol. 14:111–116. 2013. View Article : Google Scholar : PubMed/NCBI
30	Cui C, Zhang H, Guo LN, Zhang X, Meng L, Pan X and Wei Y: Inhibitory effect of NBL1 on PDGF-BB-induced human PASMC proliferation through blockade of PDGFβ-p38MAPK pathway. Biosci Rep. 36:e003742016. View Article : Google Scholar
31	Stenmark KR, Meyrick B, Galie N, Mooi WJ and McMurtry IF: Animal models of pulmonary arterial hypertension: The hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol. 297:L1013–L1032. 2009. View Article : Google Scholar : PubMed/NCBI
32	Yuan JX and Rubin LJ: Pathogenesis of pulmonary arterial hypertension: The need for multiple hits. Circulation. 111:534–538. 2005. View Article : Google Scholar : PubMed/NCBI
33	Karbowski M, Norris KL, Cleland MM, Jeong SY and Youle RJ: Role of Bax and Bak in mitochondrial morphogenesis. Nature. 443:658–662. 2006. View Article : Google Scholar : PubMed/NCBI
34	Goncharova EA, Ammit AJ, Irani C, Carroll RG, Eszterhas AJ, Panettieri RA and Krymskaya VP: PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 283:L354–L363. 2002. View Article : Google Scholar : PubMed/NCBI
35	Wang YC, Lin S and Yang QW: Toll-like receptors in cerebral ischemic inflammatory injury. J Neuroinflammation. 8:1342011. View Article : Google Scholar : PubMed/NCBI
36	Ma L, Ambalavanan N, Liu H, Sun Y, Jhala N, Bradley WE, Dell'Italia LJ, Michalek S, Wu H, Steele C, Benza RL, Chen Y, et al: TLR4 regulates pulmonary vascular homeostasis and remodeling via redox signaling. Front Biosci. 21:397–409. 2016. View Article : Google Scholar